COMPREHENSIVE HEALTHCARE SYS (CHS.CA) Stock Fundamental Analysis

Name: COMPREHENSIVE HEALTHCARE SYS (CHS) Stock
Brand: COMPREHENSIVE HEALTHCARE SYS
Rating: 4.5 (3 reviews)

Canada - TSX Venture Exchange - TSX-V:CHS - CA2046632071 - Common Stock

0.76 CAD

+0.11 (+16.92%)

Last: 1/27/2026, 7:00:00 PM

Fundamental Rating

CHS gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 9 industry peers in the Health Care Technology industry. CHS has a bad profitability rating. Also its financial health evaluation is rather negative. CHS is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

CHS had negative earnings in the past year.
In the past year CHS has reported a negative cash flow from operations.

1.2 Ratios

Looking at the Return On Assets, with a value of -127.36%, CHS is doing worse than 66.67% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-127.36%
ROE	N/A
ROIC	N/A

ROA(3y)-235.23%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CHS's Gross Margin of 60.93% is fine compared to the rest of the industry. CHS outperforms 66.67% of its industry peers.
CHS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CHS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	60.93%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y21.64%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CHS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHS has about the same amount of shares outstanding.
Compared to 1 year ago, CHS has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -38.74, we must say that CHS is in the distress zone and has some risk of bankruptcy.
CHS's Altman-Z score of -38.74 is on the low side compared to the rest of the industry. CHS is outperformed by 66.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-38.74

ROIC/WACCN/A

WACC9.09%

2.3 Liquidity

A Current Ratio of 0.06 indicates that CHS may have some problems paying its short term obligations.
CHS has a worse Current ratio (0.06) than 88.89% of its industry peers.
A Quick Ratio of 0.06 indicates that CHS may have some problems paying its short term obligations.
With a Quick ratio value of 0.06, CHS is not doing good in the industry: 88.89% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.06
Quick Ratio	0.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.03%, which is quite impressive.
CHS shows a decrease in Revenue. In the last year, the revenue decreased by -1.73%.
The Revenue has been decreasing by -5.71% on average over the past years.

EPS 1Y (TTM)83.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-114%

Revenue 1Y (TTM)-1.73%

Revenue growth 3Y-5.71%

Revenue growth 5YN/A

Sales Q2Q%14.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.